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Abstract
Single-cell RNA-sequencing (scRNA-seq) has made it possible to profile gene expression in
tissues at high resolution. An important preprocessing step prior to performing downstream
analyses is to identify and remove cells with poor or degraded sample quality using quality
control (QC) metrics. Two widely used QC metrics to identify a ‘low-quality’ cell are (i) if the
cell includes a high proportion of reads that map to mitochondrial DNA (mtDNA) encoded
genes and (ii) if a small number of genes are detected. Current best practices use these QC
metrics independently with either arbitrary, uniform thresholds (e.g. 5%) or biological con-
text-dependent (e.g. species) thresholds, and fail to jointly model these metrics in a data-
driven manner. Current practices are often overly stringent and especially untenable on cer-
tain types of tissues, such as archived tumor tissues, or tissues associated with mitochon-
drial function, such as kidney tissue [1]. We propose a data-driven QC metric (miQC) that
jointly models both the proportion of reads mapping to mtDNA genes and the number of
detected genes with mixture models in a probabilistic framework to predict the low-quality
cells in a given dataset. We demonstrate how our QC metric easily adapts to different types
of single-cell datasets to remove low-quality cells while preserving high-quality cells that can
be used for downstream analyses. Our software package is available at https://
bioconductor.org/packages/miQC.
Author summary
We developed the miQC package to predict the low-quality cells in a given scRNA-seq
dataset by jointly modeling both the proportion of reads mapping to mitochondrial DNA
(mtDNA) genes and the number of detected genes using mixture models in a probabilistic
PLOS COMPUTATIONAL BIOLOGY







Citation: Hippen AA, Falco MM, Weber LM, Erkan
EP, Zhang K, Doherty JA, et al. (2021) miQC: An
adaptive probabilistic framework for quality control
of single-cell RNA-sequencing data. PLoS Comput
Biol 17(8): e1009290. https://doi.org/10.1371/
journal.pcbi.1009290
Editor: Magnus Rattray, University of Manchester,
UNITED KINGDOM
Received: March 6, 2021
Accepted: July 20, 2021
Published: August 24, 2021
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pcbi.1009290
Copyright: © 2021 Hippen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: For the samples from
the Huntsman Cancer Institute, raw FASTQ files are
available through dbGaP (accession phs002262.
v1.p1) and processed gene count tables are
framework. We demonstrate how our QC metric easily adapts to different types of single-
cell datasets to remove low-quality cells while preserving high-quality cells that can be
used for downstream analyses.
This is a PLOS Computational Biology Methods paper.
Introduction
Recent advances in single-cell RNA-sequencing (scRNA-seq) technologies have enabled
genome-wide profiling in thousands to millions of individual cells [2]. As these technologies
are relatively costly, researchers are eager to maximize the information gain and subsequent
statistical power from each sample and experiment [3]. scRNA-seq is also extremely sensitive
to poor or degraded sample quality, which is a particular concern for tissues, such as tumors,
obtained during surgeries or other long-duration procedures [4, 5]. It is crucial that ‘compro-
mised’ cells (‘low-quality’ or ‘failed’ cell libraries in the library preparation process or cells that
were dead at the time of tissue extraction) be removed prior to downstream analyses to miti-
gate against discovered results stemming from a technical artifact instead of meaningful bio-
logical variation [6, 7]. These considerations have inspired a wealth of research into best
practices for quality control (QC) in scRNA-seq [8–10].
One QC metric widely used to identify a compromised cell is if the cell includes a high pro-
portion of sequencing reads or unique molecular identifier (UMI) counts that map to mito-
chondrial DNA (mtDNA) encoded genes. Mitochondria are heavily involved in cellular stress
response and mediation of cell death [11]. These sorts of cellular stresses can be products of
the vigorous process of cell dissociation, and the inclusion of these transcriptionally-altered
cells can affect downstream analysis outcomes [6]. Additionally, a high abundance of counts
mapping to mtDNA genes can indicate that the cell membrane has been broken, and thus
cytoplasmic RNA levels are depleted relative to the mRNA protected by the mitochondrial
membrane [12]. For these reasons, it is standard practice to remove cells with a large percent-
age of reads or UMI counts mapping to mtDNA genes using some arbitrary and uniform
thresholds, for example greater than 5% [13, 14]. However, recent work has shown these
thresholds can be highly dependent on the organism or tissue, the type of scRNA-seq technol-
ogy used, or the protocol specific decisions made as part of the disassociation, library prepara-
tion, and sequencing steps [10, 15, 16]. For instance, evidence suggests that cells that have been
treated with certain RNA-preserving reagents prior to library preparation have a much higher
mitochondrial fraction compared to fresh tissues [17]. In addition, certain tissues such as kid-
ney tissue can have a high mitochondrial metabolic activity, which can require permissive
inclusion thresholds for cells with up to 80% mitochondrial fraction [1].
Other widely used QC metrics to identify compromised cells are the total number of
sequencing reads or UMI counts in a sample and the number of unique genes that those reads
or counts map to, also known as library complexity [18, 19]. For example, if all observed UMI
counts in a cell map to only a few genes, this also suggests that the mRNA in the cell may have
been degraded or lost in one or more protocol steps. A standard approach to filter out these
cells is to filter out cells with an ad hoc threshold of less than a certain number of unique genes
detected, such as less than 100 genes. An alternative approach is to rank the cells by their total
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UMI count and visually inspect for a knee point in the data, but this approach is often arbitrary
and difficult to reproduce [20].
Current best practices filter on these QC metrics independently and often use uniform
thresholds, sometimes species-dependent thresholds, which can lead to arbitrary linear classifi-
cation boundaries (or cutoffs) that may not be appropriate for a given dataset. These cutoffs
are often conservative, leaving only a small number of the remaining cells, which offers a non-
representative sample of the tissue and constrains downstream analyses. Moreover, filtering
on these metrics independently can fail to properly interpret legitimate biological reasons for a
low score on a single QC metric, such as quiescent cell populations which will naturally have
fewer unique genes expressed, or cells involved in respiratory processes which will naturally
have higher mitochondrial expression [14].
Here, we propose an alternative approach to enable researchers to make data-driven deci-
sions about which population a given cell comes from with respect to both mtDNA fraction
and library complexity, which is adaptive across scRNA-seq datasets. We aim to create a data-
driven decision boundary that can be more inclusive to cell libraries with high library com-
plexity and higher proportion of reads mapping to mtDNA genes. Throughout the rest of the
text, we use the terms (i) a compromised cell to refer to a low-quality cell that is expected to
have few unique genes represented and a high mitochondrial fraction and (ii) an intact cell to
refer to cells that are of a high-quality (e.g. with an intact cell membrane) with a low propor-
tion of mitochondrial reads and should be included in downstream analyses [12, 21]. For a
given scRNA-seq sample, we model the cells using a latent variable model with a latent factor
representing the degree of how compromised a given cell is. We fit a finite mixture of models
in a probabilistic framework and remove cells based on the posterior probability of coming
from the compromised cell distribution. By modeling distributions of parameters for each tis-
sue sample, biological and technical variation can be accounted for in a highly adaptive, sam-
ple-specific manner, while still providing a consistent set of principles for inclusion. We
demonstrate that across a variety of tissues and experiments, our method preserves more intact
cells post-QC than uniform mitochondrial thresholds, which can be used in downstream anal-
yses. Our data-driven methodology for QC is available in a R/Bioconductor software package
at https://bioconductor.org/packages/miQC.
Results
miQC: A data-driven metric for quality control in scRNA-seq data
To motivate the need of a data-driven approach, we first explored the use of commonly used
QC thresholds to remove compromised cells in a high-grade serous ovarian cancer (HGSOC)
tissue sample (sample ID 16030X4 from [22] and described in Datasets Section in Methods).
For each cell, we calculated the percent of counts mapping to mtDNA genes and the number
of unique genes to which those counts map. As stated above, based on previous biological
knowledge, we expect intact cells to have low percent of counts mapping to mtDNA genes and
moderate to high library complexity. In contrast, compromised cells are expected to have a
large percent of counts mapping to mtDNA genes and a low library complexity. In our cancer
sample, we observed a peak of counts mapping to mtDNA genes at 13% and a wide range of
library complexity values (Fig 1A). However, as the percent of counts mapping to mtDNA
genes increases, the number of unique genes decreases significantly, suggesting these are com-
promised cells. These are the two populations of cells we aim to discover in a data-driven
manner.
Using this cancer sample, when we remove cells using a uniform and ad hoc QC threshold,
for example greater than 10% cell counts mapping to mtDNA genes as suggested by [16], we
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remove 5828 cells (88.1%) from the sample. As ovarian cancer samples presented the most
abundant mtDNA copy numbers in a broad pan-cancer comparison across 38 tumor types
[23], mitochondrial transcript content is expected to be relatively high also for intact ovarian
cancer cells compared to most normal tissues. Thus, the QC based on an arbitrary limit of 10%
is overly aggressive and renders most of the data from a sample unusable. Alternatively, if we
use a more data-driven approach that only considers the percent of counts mapping to
mtDNA genes and removes cells with greater than 3 median absolute deviations (MADs) [24,
25], we remove no cells from the sample, resulting in an overly permissive QC. Both of these
approaches fail in this scenario because they are designed for extremely high-quality datasets
with only a trivial number of compromised cells. These analyses motivated our proposed
approach that is designed to discriminate between compromised and intact cells that is adap-
tive to a spectrum of data quality in scRNA-seq data, described in the next section.
Probabilistic classifications for scRNA-seq data quality using mixtures of linear mod-
els. Because of the limitations of uniform and ad hoc QC thresholds, we aimed to use a prob-
abilistic framework that jointly models two QC metrics to predict the compromised cells in a
given dataset. We assume that for any cell i, there is a latent variable that we do not observe
Zi = 1 if the cell is considered a compromised cell and should be removed from downstream
Fig 1. Uniform and data-driven quality control (QC) thresholds for scRNA-seq data. Cells (N = 6618) from one high-grade serous ovarian cancer
(HGSOC) tissue sample (Sample ID: 16030X4) with the number of unique genes detected (x-axis) and percent of cell counts mapping to mitochondrial
(mtDNA) genes (y-axis). (A) Illustration of removing cells with a uniform QC threshold of greater than 10% cell counts mapping to mtDNA genes
(solid black line) and a more data-driven threshold of greater than 3 median absolute deviations (MADs) of the percent of counts mapping to mtDNA
genes (dotted black line). (B) Using our data-driven approach (miQC), we fit a finite mixture of standard linear regression models with two lines (black
lines) to calculate a posterior probability of being a compromised cell. (C) Cells shaded by their posterior probability of being compromised. (D)
Discarding all cells with� 75% probability of being compromised creates a data-driven QC threshold for scRNA-seq data.
https://doi.org/10.1371/journal.pcbi.1009290.g001
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analyses, and Zi = 0 if the cell library is intact. We denote π1 as the probability Pr(Zi = 1) and
π0 = 1 − π1 = Pr(Zi = 0). We also define Yi as the percent of counts in the ith cell that map to
mtDNA genes and Xi is the number of unique genes detected or found for the ith cell. Then,
we assume that conditional on Zi and Xi, the expected percent of mtDNA counts Yi is
E½YijZi ¼ z;Xi ¼ xi� ¼ fzðxiÞ ð1Þ
We note that fz represents a different function estimated for the two states z = {0, 1} (intact
or compromised cells, respectively). We assume the errors are modeled with different variance
components εiz � Nð0; s2zÞ for the two z states. By default, we assume the function fz(xi) takes
the form of a standard linear regression model fz(xi) = β0z + β1zxi where β0z represents the
mean level of percent of mtDNA counts for the two states z = {0, 1} and β1z represents the cor-
responding coefficient, which is also estimated differently for each of the two states z = {0, 1}
(Fig 1B). This finite mixture of linear regression models is also known as latent class regression
[26]. However, our approach can also use a more flexible model such as fz(xi) = μz + gz(xi)
where μz is again the mean level and gz(xi) is a nonparametric smooth function that can be esti-
mated with, for example a B-spline basis matrix (S1 Fig). Alternately, for an even simpler
model based only on mitochondrial percentage, we can also use a one-dimensional gaussian
model where fz(xi) = μz (or xi information is not used) (S1 Fig).
To estimate the parameters θ = (πz, fz) for the two states z = {0, 1}, we use an Expectation
Maximization (EM) algorithm [27] implemented in the flexmix [28] R package. Using the esti-
mated parameters from the EM algorithm, we calculate the posterior probability of a compro-
mised cell as
gZið1Þ ¼ Pr ðZi ¼ 1jYi;Xi ¼ xi; yÞ ¼
p1NðYijf1ðxiÞ; s21Þ
p1NðYijf1ðxiÞ; s21Þ þ p0NðYijf0ðxiÞ; s20Þ
ð2Þ
where N(�) represents the probability density function of a Gaussian distribution with mean
fz(xi) and variance s2z for the two states z = {0, 1}.
We use the posterior probability gZið1Þ as the data-driven threshold to exclude (or keep)
cells (Fig 1C). In our analyses, we remove cells with a greater than 75% probability of belong-
ing to the compromised cell distribution, in order to maximize the number of potentially
informative cells while still removing the cells most likely to confound downstream analyses
(Fig 1D). In the next section, we demonstrate how this threshold is adaptive across species, tis-
sues and experimental protocols. However, the posterior argument in the miQC package
can be used to adjust the posterior probability threshold, depending on the needs of a given
experiment.
We also perform two additional processing steps to account for potentially undesired
behavior in the posterior distributions. Occasionally, when a cell is far enough below the intact
distribution line and near the x-intercept of the compromised distribution line, the posterior
probability of being compromised is high (S2(A) Fig), causing it to be excluded despite its low
percentage of mitochondrial reads (S2(B) Fig). We therefore add a condition that any cell
below the intact distribution line is automatically included (S2(C) Fig). Also, some samples
have a U-shape in the boundary between kept and discarded cells. When this occurs, cells at
the bottom of the trough will be discarded, but some cells with less library complexity (farther
left) and higher percentage of mitochondrial reads (higher)—meaning they are worse in both
QC metrics being used—will be kept. In samples with a visible U-shape, we identify the cell
marked for removal with the lowest mitochondrial percentage, determine its library complex-
ity, and discard all cells with both lower complexity and higher mitochondrial percentage (S2
(D) Fig). This creates a de facto mitochondrial percentage cutoff for all cells with low library
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complexity, but is more permissive for cells with high library complexity and high mitochon-
drial percentage, which are more likely to be intact cells with a biological reason for high
mitochondrial expression than their low complexity counterparts [14]. In the miQC package,
these corrections are recommended (and the default behavior), but optional using the
keep_all_below_boundary and enforce_left_cutoff parameters.
miQC is adaptive across species, tissues, and experimental protocols
Previous work has demonstrated that the expected amount of mitochondrial activity varies
across species and tissue types. For example, one study concluded that filtering all cells above
5% cell counts mapping to mtDNA genes is appropriate for mouse samples, but that a cutoff of
10% is preferable in human samples [16]. However, it has also been demonstrated that certain
tissues, especially those with high energy requirements such as brain, kidney, and heart, have a
higher baseline mitochondrial expression [1, 29], and that mtDNA copy numbers highly vary
across tissue and cancer types [23].
Here, we consider publicly available scRNA-seq datasets and demonstrate that our miQC
approach identifies adaptive QC thresholds across species, tissue types, and experimental pro-
tocols. Specifically, we explore N = 6 datasets (described in detail in the Datasets Section in
Methods) ranging from hundreds to tens of thousands of cells from (i) two species (mouse and
human), (ii) five non-cancer tissue types (retinal, immune, brain, pancreas, menstrual blood),
(iii) one cancer tissue type (HGSOC), and (iv) two experimental protocols (plate-based and
droplet-based single cell protocols).
Using non-cancer tissues. Using mouse scRNA-seq data from retinal [30, 31] and
immune [32] cells measured on the Drop-seq and Smart-seq2 platforms, we found that miQC
identifies a similar QC threshold to using the 5% threshold found in a previous study [16] (Fig
2A, 2B and 2C). However, using mouse scRNA-seq data from brain cells measured on the
Fig 2. miQC is adaptive across species, tissues, and experimental protocols. Using publicly available scRNA-seq data from non-cancer tissues, we
calculated the number of detected genes (x-axis) and percent of cell counts mapping to mitochondrial (mtDNA) genes (y-axis) for each cell. Black lines
represent the finite mixture of linear regression models estimated from miQC to adaptively identify compromised cells across datasets. Color represents
the posterior probability of a given cell being a compromised cell (yellow is a high probability and purple is a low probability). The data span both
(A-D) mouse and (E-F) human scRNA-seq cells from non-cancer (A-B) retinal [30, 31], (C) immune [32], (D) brain [33], (E) pancreas [34], and (F)
menstrual blood tissues [35]. In addition, the data span (A, B, F) droplet-based, (C) plate-based, and (D, E) microfluidic-based protocols.
https://doi.org/10.1371/journal.pcbi.1009290.g002
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Fluidigm C1 platform [33], we found that miQC proposes a less stringent QC threshold com-
pared to the 5% threshold suggested by [16] (Fig 2D). In this case, if a 5% threshold was used,
there would be N = 1948 cells (or 64.8%) removed from the sample, which are likely to contain
intact and biologically informative cells.
In humans, previous work has shown pancreas typically expresses a large fraction of
mtDNA genes [16]. Using human scRNA-seq data from pancreas measured on the Fluidigm
C1 platform [34], our miQC approach agrees with this result and the model suggests excluding
N = 50 cells (or 7.8%) from the sample (Fig 2E) in contrast to removing N = 290 cells (or
45.5%) if using a 10% threshold as suggested for human tissues. In addition, we found using
human scRNA-seq data from menstrual blood measured on the 10x Chromium platform [35]
that our miQC approach excludes fewer cells (N = 13499 or 19.0%) from the sample (Fig 2F)
in contrast to removing N = 29129 cells (or 41%) if using a 10% threshold as suggested by [16].
Using cancer tissues. A major advantage of our data-driven miQC approach is the use of
the posterior probability threshold for inclusion, because it allows for a consistent QC metric
to be applied across all samples in a set of experiments, while still flexibly accommodating dif-
ferences in samples or tissues. This is important for experiments leveraging data collected
from across different experimental laboratory settings or at multiple times where these factors
have been shown to contribute differences in batch effects [36] or percent of counts mapping
to mtDNA genes. This is particularly true in application of scRNA-seq cancer samples, where
the high heterogeneity of tumor composition and cancer cell behavior make it especially chal-
lenging to assign one cutoff metric for all samples.
Here, we apply miQC to a set of scRNA-seq data derived from multiple human high-grade
serous ovarian tumors (HGSOC) [22] (N = 7 tumor samples described in detail in the Datasets
Section in Methods) using the 10X Chromium experimental protocol. For each cell in a
HGSOC tumor sample, we calculate the number of detected genes and the percent of cell
counts mapping to mitochondrial genes, similar to Fig 2, which resulted in wide variation of
what might be a compromised cell. However, we found that our approach miQC is able to
adaptively find QC thresholds across different tumor samples all within the same cancer type
(Fig 3). Specifically, we found miQC removes N = 1464 (29.7%), 813 (49.0%), 218 (28.5%), 47
(8.1%), 160 (10.6%), and 448 (12.0%) cells as opposed to 4683 (94.8%), 911 (55.0%), 376
(46.8%), 159 (27.4%), 250 (16.6%), and 324 (8.6%) cells if using a 10% threshold, as is suggested
in [16].
miQC is adaptive across choice of reference genome used in a data analysis
In addition to the biological factors that can affect baseline mitochondrial expression, there are
additional technological and experimental factors that can change the observed number of
counts mapping to mtDNA genes as well. For example, we found one crucial component is the
choice of the reference genome used for quantification of cell reads or UMI counts. The mito-
chondrial genome has been annotated for decades and genic content is known to be highly
conserved across animal species: 37 genes, coding for 13 mRNAs, 2 rRNAs, and 22 tRNAs
[37]. However, some reference genomes include all 37 genes where others only include the 13
protein-coding genes.
We investigated this technological confounding factor within one of the HGSOC tumor
samples (Sample ID: EOC871). We considered the scRNA-seq cell counts that were quantified
using (i) Cell Ranger [2] with the human genome reference GrCh38 (version 2020-A) filtered
to remove pseudogenes, and (ii) salmon alevin [38] with the unfiltered human genome refer-
ence GENCODE (Release 31) [39]. We found that when quantifying reads with these two dif-
ferent reference genomes, the cell counts that would have mapped to the “missing”
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mitochondrial tRNA and rRNA genes (in the GENCODE reference genome) are instead
assigned to mitochondrial-like pseudogenes on the chromosomes (in the GrCh38 reference
genome). This results in a non-uniform shift and technological inflation in the percent of cell
counts mapping to mitochondrial genes (Fig 4). These results agree with the findings of Brü-
ning et al that using a filtered transcriptome annotation causes an increase in number of reads
mapping to mitochondrial genes irrespective of quantification software used [40]. While we
compared GrCh38 and GENCODE annotations, the authors of [40] compared Ensembl anno-
tations with and without cellranger’s mkgtf function applied, indicating the effect on mito-
chondrial reads is present across several references. It is important to account for this potential
confounding factor if, for example, researchers are performing quality control on cell counts
derived with differently derived reference genomes, which we anticipate to become more rele-
vant as cancer atlases grow. Also, mitochondrial reference genomes may diverge further as
additional non-coding RNAs and pseudogenes are discovered and characterized [41].
Using a uniform 10% QC threshold to identify compromised cells (Fig 4A and 4B), we
found this removes either N = 101 and N = 230 (or 6.8% and 14.6%) using Cell Ranger and
salmon alevin, respectively, when using two different reference genomes, despite these being
the exact same cell libraries, just being quantified with two different reference genomes. Inter-
estingly, we also found differences in which cells are removed depending on the choice of ref-
erence genome with a greater fraction removed by Cell Ranger (Fig 4C). In contrast, we found
our miQC approach (Fig 4D and 4E) is able to flexibly identify different QC thresholds when
using two different reference genomes, removing a more similar set of cells: N = 160 cells and
N = 136 cells (or 10.6% and 8.8%) using Cell Ranger and salmon alevin, respectively (Fig 4F).
This demonstrates our data-driven approach is able to adjust for differences in this technologi-
cal confounding factor of diverging mitochondrial annotation in the quantification step of the
analysis of scRNA-seq data.
Fig 3. miQC is adaptive across different samples within same cancer type. scRNA-seq data from human high grade serous ovarian cancer (HGSOC)
samples from (A-B) the Huntsman Cancer Institute (Sample IDs: 16030X2, 16030X3) and (C-F) the University of Helsinki (Sample IDs: EOC1129,
EOC50, EOC871, EOC482). (Data from remaining Huntsman Cancer Institute sample, ID 16030X4, is depicted in Fig 1). We calculated the number of
detected genes (x-axis) and percent of cell counts mapping to mitochondrial (mtDNA) genes (y-axis) for each cell. Black lines represent the finite
mixture of linear regression models estimated from miQC to adaptively identify compromised cells. Color represents the posterior probability of a
given cell being a compromised cell (yellow is a high probability and purple is a low probability).
https://doi.org/10.1371/journal.pcbi.1009290.g003
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miQC minimizes cell type-specific sub-population bias
A standard downstream scRNA-seq data analysis is identifying cell types in a tissue or tumor
sample and detecting differences between cell types [25]. A crucial component of this analysis
is to have sufficient statistical power to detect differences between cell types, which depends on
having appropriate sample sizes of measured cells—and the choice of QC metrics and thresh-
olds directly impacts the number of cells employed in these downstream analyses. For exam-
ple, in application of unsupervised clustering if a large number of cells are removed post-QC,
the number of cells per cluster, and even the number of clusters discovered, can be affected.
Therefore, it is important to evaluate whether the choice of QC metric and corresponding
threshold do not significantly negatively impact the unsupervised clustering results. In fact,
[42] argued “although more stringent filtering tended to be associated with an increase in
accuracy, it tended to plateau and could also become deleterious. Most of the benefits could be
achieved without very stringent filtering and minimizing subpopulation bias”, where sub-pop-
ulation bias is defined as disproportionate exclusion of certain cell populations.
Here, we aimed to investigate whether our miQC approach resulted in minimized sub-pop-
ulation bias, as described by [42], compared to the standard recommended approach [16] of
using a uniform QC threshold of 10% of cell counts mapping to mtDNA genes. Using one
HGSOC tumor sample (Sample ID 16030X4), we preprocessed and normalized the scRNA-
seq data according to [25] followed by applying dimensionality reduction using the Uniform
Fig 4. miQC is adaptive across the choice of reference genome used. Cells (N = 1733) from one high-grade serous ovarian cancer (HGSOC) tissue
sample (Sample ID: EOC871) with the number of unique genes found (x-axis) and percent of cell counts mapping to mitochondrial (mtDNA) genes (y-
axis). Quantification of cell counts was performed with (A) Cell Ranger using the GrCh38 reference genome (version 2020-A) and (B) salmon alevin
with the GENCODE reference genome (release 31). In both (A-B), we use a 10% mtDNA threshold (as recommended by Osorio and Cai [16]) for this
human cancer sample to remove compromised cells. (C) A confusion matrix of how cells are filtered differently by this uniform threshold using the
different reference genomes, resulting in a large number of cells removed after QC using either reference genome, but differences in which cells are
removed depending on the choice of reference genome. (D-E) Using the same tissue sample as (A-C), but here we use our miQC approach to fit a finite
mixture of standard linear regression models with two lines (black lines) to calculate the posterior probability of being a compromised cell. (F) A
confusion matrix of which cells are filtered by our miQC approach which not only results in a larger number of predicted intact cells after QC, but also
results in a smaller number of discrepancies between which cells are included after QC.
https://doi.org/10.1371/journal.pcbi.1009290.g004
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Manifold Approximation and Projection (UMAP) [43] representation. The percent of cell
counts mapping to mtDNA genes in this representation is shown in (Fig 5A). Using the top 50
principal components, we performed unsupervised clustering using the mini-batch k-means
(mbkmeans) algorithm [44] implemented in the mbkmeans [45] R/Bioconductor package for
unsupervised clustering to identify cell types, which is a scalable version of the widely-used k-
means algorithm [46–48] (Fig 5B). The number of clusters (k = 6) was determined using an
elbow plot with the sum of squared errors (S3 Fig). Using these k = 6 clusters, we compared
proportions of cells belonging to each predicted cluster using (i) no filtering, (ii) our miQC
threshold, and (iii) the uniform QC threshold of 10% of cell counts mapping to mtDNA genes
(Fig 5C, 5D and 5E).
We found that the cells in cluster 4 (red bar in Fig 5) were almost entirely removed by
miQC and the 10% recommended 10% threshold [16], respectively (cluster 4: 99.6%, 100%).
These cells had an average mitochondrial fraction of 68.9% (Fig 5A). We can reasonably infer
that those are compromised cells, and as such excluding them from a downstream analysis is
appropriate. In contrast, we found that for all other clusters miQC removed far fewer cells
than the 10% threshold approach (cluster 1: 6.2%, 83.6%; cluster 2: 82.6%, 97.6%; cluster 3:
2.6%, 53.2%; cluster 5: 60.3%, 96.1%; cluster 6: 5.4%, 75.9%). This suggests miQC preserves
more cells within each predicted cluster and minimizes sub-population bias, compared to the
uniform threshold approach of a 10% cutoff.
Methods
Ethics statement
All patients participating in the study provided written informed consent. An Institutional
Review Board approved the protocol at University of Pennsylvania (832353), Johns Hopkins
University (00009288), Univeristy of Utah (118086), and University of Colorado (21–2761).
Fig 5. miQC minimizes sub-population bias in unsupervised clustering. Cells (N = 6691) from one high-grade serous ovarian cancer (HGSOC)
tissue sample (Sample ID: 16030X4). (A) UMAP representation of cells, colored by percent of cell counts mapping to mtDNA genes. (B) Predicted
cluster labels for k = 6 cell types identified using the mini-batch k-means (mbkmeans) algorithm for unsupervised clustering. (C) Total number of cells
preserved within each predicted cluster group using three filtering approaches: no filtering (‘All cells’), miQC filtering, or removing all cells greater than
10% mtDNA content. (D) UMAP representation of cells colored by whether miQC keeps (red) or removes (gray) cells post-QC. (E) Similar as (D), but
using a uniform 10% threshold for mtDNA content.
https://doi.org/10.1371/journal.pcbi.1009290.g005
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The use of clinical material from University of Helsinki was approved by The Ethics Commit-
tee of the Hospital District of Southwest Finland (ETMK) under decision number EMTK: 145/
1801/2015.
Datasets
Non-cancer tissue scRNA-seq datasets. We obtained non-cancer tissue scRNA-seq data-
sets for the studies [30], [31], [32], [33], and [34] from the R/Bioconductor data package
scRNAseq [49]. We obtained the scRNA-seq data from [35] from the Sequence Read Archive
(SRA) (accession code SRP135922). All datasets were processed using scater [24], as described
in the “Preprocessing scRNA-seq datasets” section. Table 1 contains a summary of the non-
cancer datasets used: the organism, the tissue, the experimental protocol, and the number of
cells prior to QC for each dataset.
Cancer tissue scRNA-seq datasets. The N = 7 HGSOC tumor samples were collected and
sequenced at Huntsman Cancer Institute, Utah, USA (N = 3) and at University of Helsinki,
Finland (N = 4).
For the samples from the Huntsman Cancer Institute, raw FASTQ files are available
through dbGaP (accession phs002262.v1.p1) and processed gene count tables are available
through GEO (accession GSE158937) [22]. Complete details of the experimental protocol and
sequencing steps followed for these tumor samples are provided in [22], but in brief library
prepration was performed using 10x Genomics 3’ Gene Expression Library Prep v3, and
sequencing was done on an Illumina NovaSeq instrument. Quantification for these samples
was performed using salmon alevin [38] with a index genome generated from GENCODE v31
[39].
Genome data for the University of Helsinki samples has been deposited at the European
Genome-phenome Archive (EGA) which is hosted at the EBI and the CRG, under accession
number EGAS00001005066. The samples were taken as a part of a larger study cohort, where
all patients participating in the study provided written informed consent. The study and the
use of all clinical material have been approved by The Ethics Committee of the Hospital Dis-
trict of Southwest Finland (ETMK) under decision number EMTK: 145/1801/2015. Immedi-
ately after surgery, tissue specimens were incubated overnight in a mixture of collagenase and
hyaluronidase to obtain single-cell suspensions. Cell suspensions were passed through a 70-
μm cell strainer to remove cell clusters and debris and centrifuged at 300 x g. Cell pellets were
resuspended in a resuspension/washing buffer (1X PBS supplemented with 0.04% BSA) and
washed three times. scRNA-seq libraries were prepared with the Chromium Single Cell 3’
Reagent Kit v. 2.0 (10x Genomics) and sequenced on an Illumina HiSeq4000 instrument.
Using the raw FASTQ files, we performed the quantification step with two different methods
to obtain two different UMI counts matrices. First, Cell Ranger (version 3.1.0) [2] was used to
perform sample de-multiplexing, alignment, filtering, and barcode and UMI quantification.
Table 1. Description of non-cancer tissue scRNA-seq datasets. Columns from left to right include the source, the organism, the type of tissue, the experimental protocol,
and the number of cells prior to QC in each dataset.
Source Organism Tissue Protocol Cells
Richard et al. [32] Mouse T cells Smart-seq2 572
Zeisel et al. [33] Mouse Brain Fluidigm C1 3005
Shekhar et al. [31] Mouse Retina Drop-seq 44994
Macosko et al. [30] Mouse Retina Drop-seq 49300
Lawlor et al. [34] Human Pancreatic islets Fluidigm C1 638
Wang et al. [35] Human Menstrual blood 10X Chromium 71032
https://doi.org/10.1371/journal.pcbi.1009290.t001
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GRCh38.d1.vd1 genome was used as reference and GENCODE v25 for gene annotation. Sec-
ond, salmon alevin [38] (version 1.4.0) was also used with GRCh38.p13 as reference genome
and GENCODE v34 for gene annotation. Table 2 contains a summary of the cancer datasets
used, including the source, the organism, the location from where the tumors were obtained,
and the number of cells prior to QC in each dataset.
Data analysis
Preprocessing scRNA-seq datasets. We processed the gene-by-cell matrix from each
dataset using the scater [24] R/Bioconductor package, including calculating the number of
unique genes represented and the percent of reads or UMI counts mapping to mtDNA genes.
At this step, we removed any cells with fewer than 500 total reads or fewer than 100 unique
genes represented, which we considered to be unambiguously failed.
To represent the effect of miQC on downstream analyses, we calculated and plotted the
Uniform Manifold Approximation and Projection (UMAP) representation of the single-cell
expression data using functions in the scater package. We chose to highlight how miQC filter-
ing specifically affects clustering results using the mbkmeans package, which uses mini-batches
to quickly and scalably produce k-means clustering assignments [45]. We ran mbkmeans on a
reduced representation of our expression data, the first 50 principal components as calculated
via scater. All visual representations and figures were generated using the ggplot2 R package
[50].
miQC software implementation. We used the R package flexmix [28] to fit the finite mix-
ture of linear (or non-linear) models, depending on the functional form of fz(xi) used. The flex-
mix R packages performs estimation of the parameters using an Expectation-Maximization
(EM) algorithm [27]. Like all implementations of the EM algorithm, flexmix is not guaranteed
to find a global maximum likelihood, meaning that users should check for convergence across
multiple initializations. In our case with a finite mixture of two standard linear regression
models, we found that flexmix converges to extremely similar parameters for each iteration of
a given sample, but that the order of distributions given in each iteration is non-deterministic.
Therefore, we assumed that the distribution with the greater y-intercept, meaning the distribu-
tion with higher percent of cell counts mapping to mtDNA genes at low library complexity,
was the compromised cell distribution. The parameters estimated from each mixture model
were used to calculate the posterior probability of a cell coming from the compromised cell
distribution. Our miQC software is available as an R/Bioconductor package under a BSD-
3-Clause License at https://bioconductor.org/packages/miQC. The code used to download
Table 2. Description of human high-grade serous ovarian cancer (HGSOC) tissue scRNA-seq datasets. Columns
from left to right include the source, the organism, the location from where the tumors were obtained, and the number
of cells prior to QC in each dataset. Huntsman Cancer Institute samples were processed with the 10x Genomics 3’
Gene Expression Library Prep v3 protocol, and University of Helsinki samples were processed with Chromium Single
Cell 3’ Gene Expression v2 protocol.
Source Sample ID Location Cells
Weber et al. (2020) [22] 16030X2 Huntsman Cancer Institute 4939
Weber et al. (2020) [22] 16030X3 Huntsman Cancer Institute 1725
Weber et al. (2020) [22] 16030X4 Huntsman Cancer Institute 6691
Novel as part of manuscript EOC1129 University of Helsinki 1086
Novel as part of manuscript EOC50 University of Helsinki 930
Novel as part of manuscript EOC871 University of Helsinki 1733
Novel as part of manuscript EOC482 University of Helsinki 3879
https://doi.org/10.1371/journal.pcbi.1009290.t002
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datasets, perform the analyses, and reproduce the figures is available at https://github.com/
greenelab/mito-filtering.
Discussion
One critical assumption of our model is that mitochondrial reads are not informative in terms
of biological variation. While this is true in many contexts, there are some contexts where high
mitochondrial expression is biologically relevant and informative. For instance, scRNA-seq
data has shown that aberrant mitochondrial activation is implicated in development of poly-
cystic ovary syndrome (PCOS) [51]. Removing all cells with a large percentage of mitochon-
drial reads in a PCOS study would therefore hinder much of the downstream analysis. More
broadly, metabolic shifts between oxidative phosphorylation and glycolysis, an important indi-
cator of cell proliferation, can also increase or decrease mitochondrial expression [52, 53].
Generally, researchers are able to assess if mitochondrial expression may be relevant to
their experimental question at hand. In the majority of cases, cells with a large percentage of
mitochondrial reads–especially when paired with few uniquely expressed genes or low num-
bers of total counts (reads or UMIs)–can be reasonably interpreted as a sign of cell damage
and those cells should be discarded.
Our miQC mixture model is designed for scenarios in which there are a non-trivial amount
of compromised cells and the amount of compromised cells might vary across samples or
experiments. For scRNA-seq data generated from archived tumor tissues, this is often the case.
However, in optimal conditions where there are no or few damaged cells, the mixture model
may not be able to accurately estimate parameters for the compromised cell distribution, as
there might only be a handful of compromised cells. In this case, the model is thus liable to
choose very similar parameters for the two distributions, causing the probabilistic assignments
for individual cells to be unstable and good cells to be excluded unnecessarily. As an example,
our tumor sample EOC50 (Fig 3D) had no cells with an extremely high mitochondrial fraction,
meaning the intercept for the “compromised” cell distribution was fitted at a much lower
value than the other tumors. In this case, miQC actually excluded more cells than a simple
10% mitochondrial threshold did. With this in mind, for cases with few to no concerns about
tissue quality, we recommend using Median Absolute Deviation (MAD) as a data-driven
approach for filtering out a small number of damaged cells [54]. We also caution against using
miQC on data that has already been filtered by some prior preprocessing step, and recommend
users of miQC be aware of any filtering that has been done on their data, especially in the case
of public datasets.
It is possible that not only tissue types may have different baselines of mitochondrial
expression, but that the baselines would also vary across the cell types within a heterogeneous
tissue, such as a dissociated tumor [16]. This suggests an extension of our miQC approach
for future development where the intact/compromised distribution parameters could be esti-
mated for each cell type independently. However, in most scRNA-seq experiments involving
tissues, cell type identities are not known a priori and cannot be determined without first per-
forming QC. Stratifying by cell type is thus currently not advisable for the main uses of
miQC.
miQC is a highly flexible model, and as such it is conceptually and practically simple to
adjust to a given user’s needs. We have designed the miQC package with the most common
use-cases built in, with the two most commonly used QC metrics, percent mitochondrial reads
and number of unique genes, used to build the model. However, there are many other metrics
that can be used for QC, including percent of reads mapping to ribosomal genes, total number
of UMIs detected, number of features to which 50% of the reads map, etc. These metrics can
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be calculated using scater [24], with which miQC is designed to work. These metrics can then
be passed to flexmix using a similar notation as any linear model in R (see miQC software
package for examples). Many of these metrics will be highly correlated with one another, so we
caution users to check for multicollinearity before including a large number of variables in
their model [55].
Conclusion
Ensuring the quality of scRNA-seq data is essential for robust and accurate transcriptomic
analyses. Percent of reads mapping to the mitochondria is a very useful proxy for cell damage,
but existing QC methods do not do justice to the myriad of biological and experimental factors
relevant to mitochondrial expression. The standard wisdom of removing all cells with greater
than 5% (or 10%) mitochondrial counts is unnecessarily stringent in many tissue types, espe-
cially cancer tissues, causing a massive loss of potentially informative cells. Our new method,
miQC, offers a probabilistic approach to identifying high-quality cells within an individual
sample, based on the assumption that there are both intact and compromised cells within the
samples with associated characteristics. This method is flexible and adaptive across experimen-
tal platforms, organism and tissue types, and disease states. It is robust to technical differences
that alter standard QC metrics, such as differences in reference genome. It also maximizes the
information gain from an individual experiment, often preserving hundreds or thousands of
potentially informative cells that would be thrown out by uniform QC approaches. miQC is
now available as a user-friendly R package available at https://bioconductor.org/packages/
miQC, allowing researchers to tailor their QC to the needs of a given scRNA-seq dataset and
experiment in a consistent way.
Supporting information
S1 Fig. miQC is extensible to a combination of linear and non-linear models. (A) A mixture
model on high-grade serous ovarian tumor data, where the intact cell distribution is modeled
linearly and the compromised cell distribution is modeled using a b-spline.(B) Posterior prob-
ability of tumor cells belonging to compromised distribution as fitted with a spline model.
(C) Cells with greater than 75% posterior probability of being compromised are marked for
removal, after the two default corrections (keep_all_below_boundary = TRUE and
enforce_left_cutoff = TRUE). (D-F) The same tumor, but with a one-dimensional
Gaussian mixture model on percent mitochondrial reads.
(TIF)
S2 Fig. Conditional corrections for linear models. (A) The posterior distribution of linear
mixture models from Fig 1, shown again for reference. (B) Filtering based only using a 66%
posterior threshold with no default corrections (keep_all_below_boundary = FALSE
and enforce_left_cutoff = FALSE) Low-mitochondrial cells slated for removal are
circled in black. (C) Same as (B), but including the keep_all_below_boundary = TRUE
parameter, where all cells with lower mitochondrial fraction than the predicted intact distribu-
tion are kept. This prevents the group of cells in the bottom center from being excluded. (D)
Same as (B), but including both default corrections (keep_all_below_boundary =
TRUE and enforce_left_cutoff = TRUE). This corrects the U-shape boundary. The
excluded cell with the lowest mitochondrial percentage is identified, and any cell with both
greater mitochondrial percentage and lower library complexity is excluded.
(TIF)
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S3 Fig. Selecting an appropriate number of clusters for tumor data. We ran mbkmeans on
our tumor data for a range of k from 2 to 10. Based on the within cluster sum of squares
(WCSS), we proceeded with 6 clusters.
(TIF)
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